Literature DB >> 3029157

The dissociation of renin and aldosterone during critical illness.

J W Findling, V O Waters, H Raff.   

Abstract

A syndrome of elevated PRA accompanied by inappropriately low plasma aldosterone (ALDO) levels has been identified in some critically ill patients. To determine whether this phenomenon is due to a disturbance in factors that stimulate ALDO, we measured PRA, angiotensin II (AII), potassium (K+), and ACTH levels in 83 patients admitted to an intensive care unit. In 59 patients, PRA was greater than 2.0 ng/ml X h. Of these, 24 had an ALDO to PRA ratio (ALDO/PRA) below 2 (group I), and 35 had an ALDO/PRA ratio of 2 or more (group II). An ALDO/PRA ratio below 2 was deemed inappropriately low. Despite markedly elevated PRA [34 +/- 12 (+/- SE) ng/ml X h], the group I patients had inappropriately low ALDO levels (19 +/- 5 ng/dL). Patients in group II had significantly higher ALDO levels (48 +/- 6 ng/dL) despite lower PRA (9 +/- 1 ng/ml X h). AII levels were appropriately elevated in group I (39 +/- 26 pg/mL) and significantly greater (P less than 0.5) than those in group II. PRA correlated well with AII in both groups. There were no differences in plasma ACTH or K+ in these 2 groups, and plasma cortisol levels were similarly elevated in both groups of patients. Of 66 consecutively studied patients, 14 (21%) had inappropriate ALDO (group I). Mortality was significantly greater in group I (75%) than in group II (46%; P less than 0.001). In summary, a significant subset (21%) of seriously ill patients have inappropriately low ALDO levels despite elevated PRA. This dissociation is not due to an impairment of AII production or changes in plasma ACTH or K+. This phenomenon is associated with a higher mortality during critical illness. In light of evidence of decreased adrenal androgen secretion during severe illness, this dissociation of renin and aldosterone may represent an additional adrenal adaptation designed to promote cortisol production in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029157     DOI: 10.1210/jcem-64-3-592

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Is there a role for dehydroepiandrosterone replacement in the intensive care population?

Authors:  Ketan K Dhatariya
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

2.  Immunolocalization of 3β-hydroxysteroid dehydrogenase in human adrenal cortex and in its disorders.

Authors:  Hironobu Sasano; J Lan Mason; Nobuaki Sasano; Hiroshi Nagura
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

3.  The effect of high altitude on saliva aldosterone and glucocorticoid concentrations.

Authors:  C J McLean; C W Booth; T Tattersall; J D Few
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

4.  Mineralocorticoid deficiency in hemorrhagic shock.

Authors:  Nikolai S Tolstoy; Majid Aized; Morgan P McMonagle; Daniel N Holena; Jose L Pascual; Seema S Sonnad; Carrie A Sims
Journal:  J Surg Res       Date:  2012-05-25       Impact factor: 2.192

5.  Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients.

Authors:  L F Span; A R Hermus; A K Bartelink; A J Hoitsma; J S Gimbrère; A G Smals; P W Kloppenborg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 6.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

7.  Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure.

Authors:  D du Cheyron; A Lesage; C Daubin; M Ramakers; P Charbonneau
Journal:  Intensive Care Med       Date:  2003-08-28       Impact factor: 17.440

8.  Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of interleukin-6 and outcome in critically ill patients with liver cirrhosis.

Authors:  Damien du Cheyron; Bruno Bouchet; Brigitte Cauquelin; Damien Guillotin; Michel Ramakers; Cédric Daubin; Jean-Jacques Ballet; Pierre Charbonneau
Journal:  Intensive Care Med       Date:  2007-09-29       Impact factor: 17.440

Review 9.  Immune Effects of Corticosteroids in Sepsis.

Authors:  Nicholas Heming; Sivanthiny Sivanandamoorthy; Paris Meng; Rania Bounab; Djillali Annane
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

10.  Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury.

Authors:  Daniel E Leisman; Tiago D Fernandes; Vanesa Bijol; Mabel N Abraham; Jake R Lehman; Matthew D Taylor; Christine Capone; Omar Yaipan; Rinaldo Bellomo; Clifford S Deutschman
Journal:  Kidney Int       Date:  2020-08-31       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.